These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 76257)
21. Changes in macrophage status in vivo during infection with and immunity to Leismania enrietti. Poulter LW Cell Immunol; 1976 Nov; 27(1):17-25. PubMed ID: 991281 [No Abstract] [Full Text] [Related]
22. Dermal exudate macrophages. Induction in dermal chambers and response to lymphokines. Goihman-Yahr M; Ulrich M; Noya-León A; Rojas A; Convit J Clin Exp Immunol; 1975 Nov; 22(2):359-63. PubMed ID: 1212821 [TBL] [Abstract][Full Text] [Related]
25. The effect of levamisole on human lymphocyte mediator production in vitro. Whitcomb ME; Merluzzi VJ; Cooperband SR Cell Immunol; 1976 Feb; 21(2):272-7. PubMed ID: 769994 [No Abstract] [Full Text] [Related]
26. Mastocytoma cell migration in vitro: inhibition by MIF-containing supernatants. Cohen MC; Zeschke R; Bigazzi PE; Yoshida T; Cohen S J Immunol; 1975 May; 114(5):1641-3. PubMed ID: 164509 [TBL] [Abstract][Full Text] [Related]
27. Possible role of macrophage glycolipids as receptors for migration inhibitory factor (MIF). Higgins TJ; Sabatino AP; Remold HG; David JR J Immunol; 1978 Sep; 121(3):880-6. PubMed ID: 357658 [TBL] [Abstract][Full Text] [Related]
28. Biological effects and characteristics of antilymphokines. Yoshida T; Cohen S Ann N Y Acad Sci; 1979; 332():408-10. PubMed ID: 394638 [No Abstract] [Full Text] [Related]
30. Macrophage spreading inhibition test as an alternate method for in vitro assessment of cell-mediated immunity against Entamoeba histolytica. Haq A; Sharma A; Ahmad S; Khan N Trop Med Parasitol; 1986 Sep; 37(3):248-50. PubMed ID: 2878487 [TBL] [Abstract][Full Text] [Related]
31. Isolation of a guinea pig macrophage glycolipid with the properties of the putative migration inhibitory factor receptor. Liu DY; Petschek KD; Remold HG; David JR J Biol Chem; 1982 Jan; 257(1):159-62. PubMed ID: 7031060 [TBL] [Abstract][Full Text] [Related]
32. Macrophages migration inhibition by complement activators, migration inhibitory factor, and Lotus fucolectin: evidence for common involvement of cell-associated esterase activity. Leu RW; Herriott MJ Cell Immunol; 1982 Apr; 68(2):302-10. PubMed ID: 7046953 [No Abstract] [Full Text] [Related]
33. Production of an antibody against guinea pig MIF. I. Specificity of the anti-MIF antibody. Onozaki K; Haga S; Miura K; Ichikawa M; Hashimoto T Cell Immunol; 1979 Dec; 48(2):258-66. PubMed ID: 389441 [No Abstract] [Full Text] [Related]
35. [A simplified macrophage migration inhibition test to measure T-cell derived immunity in man]. Rehn K; Baake H; Hunstein W Klin Wochenschr; 1975 Apr; 53(8):397-9. PubMed ID: 802669 [TBL] [Abstract][Full Text] [Related]
36. Immune deviation: demonstration of split tolerance in vitro by inhibition of macrophage migration. Dasgupta A Clin Exp Immunol; 1971 Feb; 8(2):173-6. PubMed ID: 5573422 [TBL] [Abstract][Full Text] [Related]
37. The effect of lymphokines on macrophage accumulation and disappearance in the peritoneal cavity. D'Silva H; Yoshida T; Cohen S J Exp Pathol; 1983; 1(1):61-9. PubMed ID: 6400639 [TBL] [Abstract][Full Text] [Related]
38. The role of macrophages in incontinentia pigmenti histologica. Migration and phagocytosis of macrophages. Takematsu H; Seiji M J Dermatol; 1980 Oct; 7(5):335-9. PubMed ID: 7009683 [No Abstract] [Full Text] [Related]
39. [Macrophage migration inhibition test and delayed hypersensitivity]. Onoue K; Yamamoto Y Nihon Rinsho; 1978; 36(5):1051-8. PubMed ID: 353326 [No Abstract] [Full Text] [Related]
40. Lymphokines. I. Use of insoluble concanavalin A for the production of migration inhibitory factor in guinea pig lymphocyte cultures. Friedrich W; Lazary S; Geczy C; de Weck AL Int Arch Allergy Appl Immunol; 1975; 49(4):504-18. PubMed ID: 1099010 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]